|
NONO expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.944200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.244300E-02 |
| Normal-vs-Stage2 |
5.142000E-01 |
| Normal-vs-Stage3 |
3.141400E-01 |
| Normal-vs-Stage4 |
1.186770E-01 |
| Stage1-vs-Stage2 |
5.347600E-01 |
| Stage1-vs-Stage3 |
4.281000E-01 |
| Stage1-vs-Stage4 |
9.862400E-01 |
| Stage2-vs-Stage3 |
9.583200E-01 |
| Stage2-vs-Stage4 |
6.220000E-01 |
| Stage3-vs-Stage4 |
5.608000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.580000E-02 |
| Normal-vs-AfricanAmerican |
1.823260E-03 |
| Normal-vs-Asian |
5.412200E-02 |
| Caucasian-vs-AfricanAmerican |
2.593900E-02 |
| Caucasian-vs-Asian |
4.170000E-01 |
| AfricanAmerican-vs-Asian |
1.531760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.044400E-02 |
| Normal-vs-Female |
1.399250E-01 |
| Male-vs-Female |
2.313200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.601800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.702620E-01 |
| Normal-vs-Age(61-80Yrs) |
4.755800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.638600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.875400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.903980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.121800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.844600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.608400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.385000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.604610E-01 |
| Classical-VS-Follicular |
1.779920E-03 |
| Classical-VS-Other |
6.359800E-01 |
| Classical-VS-Normal |
8.579900E-03 |
| Tall-VS-Follicular |
3.895000E-01 |
| Tall-VS-Other |
8.383800E-01 |
| Tall-VS-Normal |
5.475400E-01 |
| Follicular-VS-Other |
5.290800E-01 |
| Follicular-VS-Normal |
5.770200E-01 |
| Other-VS-Normal |
6.878600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.370600E-01 |
| Normal-vs-N1 |
9.010600E-01 |
| N0-vs-N1 |
2.967400E-01 |
|
|
